Antiallergy drugs and respiratory diseases in children.

Citation
L. Donato et al., Antiallergy drugs and respiratory diseases in children., ARCH PED, 6, 1999, pp. 98S-104S
Citations number
12
Categorie Soggetti
Pediatrics
Journal title
ARCHIVES DE PEDIATRIE
ISSN journal
0929693X → ACNP
Volume
6
Year of publication
1999
Supplement
1
Pages
98S - 104S
Database
ISI
SICI code
0929-693X(1999)6:<98S:ADARDI>2.0.ZU;2-W
Abstract
Second generation antihistamines (anti H1) are effective for seasonal and p erannual rhinoconjunctivitis curative or preventive treatment in children. They are better tolerated than first generation drugs. They probably do not act specifically against asthma itself but are nevertheless useful for rel ief of nasal obstruction, which is an asthmogenic factor frequently linked with bronchial asthma. The therapeutic relevance of oral ketotifen and inha led chromones (sodium cromoglycate, nedocromil sodium) is unequally conside red among pediatricians. However, their efficacy has been clearly demonstra ted as a ground treatment in mild-to-moderate asthmatic children. Chromones are also useful in preventing exercise-induced asthma. Because of their lo w cost and the lack of potential side effects, mid according to the guideli nes established in 1997 by the National Heart, Lung and Bloom Institute, th ey should be prescribed at first sight in these indications. (C) 1999 Elsev ier, Paris.